Skip to main content
OpenTrials
Completed

NCT Number: NCT06088706

Evaluation of the Effect of Different Doses of Ozone Therapy on Pain and Function of Patients With Knee Osteoarthritis

This study is designed as a randomized clinical trial that will be conducted in Hazrat Rasool Akram Hospital in Tehran. Patients with knee osteoarthritis were selected based on the study entry criteria and written consent was obtained from them. Then, by random assignment, patients will be divided into three treatment groups: control group (under oxygen gas injection), intervention group 1 (intra-articular injection of ozone with a dose of 20 micrograms) and intervention group 2 (intra-articular injection of ozone with a dose of 40 micrograms).

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Sports and Exercise Medicine, School of Medicine, Iran University of Medical Sciences

Tehran, 14496-14535, Iran

About this study

This research is a type of randomized clinical trial (RCT) in which the studied samples will be selected from the patients with knee osteoarthritis referring to Hazrat Rasool Akram hospital by available sampling method. All the stages of this research will be done with the approval of the ethics committee of the Research Vice-Chancellor of Iran University of Medical Sciences, and written consent will be obtained from all the participants in this research.

The population studied in this research will be made up of knee osteoarthritis sufferers who, according to the announcements that will be posted at the hospitals of Iran University of Medical Sciences in Tehran, will come from all urban areas to participate in this study to Hazrat Rasool Akram Hospital.) will be called and after meeting the conditions for entering the research, they will be randomly placed in one of the proposed treatment groups.

The intervention groups in this research are:

  • Control group - intra-articular injection of oxygen without ozone
  • Intervention group 1- Intra-articular injection of ozone with a dose of 20 micrograms
  • Intervention group 2- Intra-articular injection of ozone with a dose of 40 micrograms In the next step, a summary of the evaluation and treatment plans for the participants will be stated in simple language, and after that, the results of the research on the studied patients will be evaluated and the results will be recorded. Then, according to their groups, the patients will be subjected to exercise therapy interventions under supervision in the clinic or based on the Internet for six weeks. Before and in the second week, the first month and the third month after the intervention, patients will be evaluated with VAS, knee range of motion, WOMAC questionnaires and functional tests (6MWT and Timed Up and Go Test).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having primary knee osteoarthritis grade 2 and 3 according to the doctor's diagnosis and based on the Kellgren and Lawrence criteria (the presence of knee pain, morning dryness for less than 30 minutes, crypts during movement and radiological signs of osteoarthritis including joint space reduction, subchondral bone sclerosis and osteophyte formation in knee)
  • Age 50-75 years
  • Suffering from continuous knee pain for at least six months and with a severity of at least 4 based on the VAS criteria in physical activities such as going up and down the stairs, sitting for a long time and squatting
  • Ability to walk independently for at least 30 meters
  • Body mass index equal to or less than 35
  • Complete consent of the patient to participate in the research
  • Balanced mental state

Exclusion criteria

  • History of intra-articular injections in the knee during the last six months
  • Suffering from neuromuscular diseases
  • Presence of acute traumatic injury in other ligaments and structures of the knee joint as confirmed by a specialist doctor
  • History of previous surgery or injury in the knee and other joints of the lower limbs during the last year
  • Presence of bone implants
  • The presence of new fractures in the lower limbs during the last year
  • Getting malignant tumors
  • Participation in sports therapy and physiotherapy programs during the last three months

Treatment and study plan

Intra-articular injection of ozone

Procedure

the patient is lying on the bed with his knee flexed at about 45 degrees. Then The syringe containing ozone is prepared by a sports medicine assistant and covered with a label so that the clinician is not aware of the injected ozone dose. Lateral Approach will be used for intra-articular injection. after preparation and drape of the desired position and aspiration, the ozone composition will be injected into the joint. In order to inject for this group, a 10 cc needle and a predetermined concentration of 20 and 40 micrograms ozone are used under sterile conditions. The duration of the injection will be 15-20 seconds. The number of sessions considered for injection will be three sessions, once a week for three weeks. The second and third injection will be done under the same conditions as the first session. In this study, Ozonette Sedecal device ( Spain) will be used. And the exercise therapy protocol is performed.

Primary outcomes

  1. Questionnaire evaluations womac

    Time frame: before the intervention and two weeks later, one month and three months after the intervention

    Western Ontario and McMaster Universities Osteoarthritis Index questionnaire or WOMAC for short:

    This questionnaire has 24 items which are arranged in three sections.

    • The first part examines pain with five items in different positions of walking, climbing stairs, while resting in bed, while sitting or sleeping, and standing.
    • The second part examines morning dryness and joint stiffness at the end of the day with two items.
    • The third section examines the patient's functional activities in different situations with seventeen items.

    It is worth mentioning that the translation, localization and validation of WOMAC questionnaire in Iran was done in 2014 by Dr. Ebrahimzadeh and his colleagues.

  2. Visual Analogue Scale

    Time frame: before the intervention and two weeks later, one month and three months after the intervention

    Feeling pain in the knee with vas criteria

Secondary outcomes

  1. range of motion

    Time frame: before the intervention and two weeks later, one month and three months after the intervention

    In this research, the active range of motion of the knee is measured with a goniometer and recorded in degrees

  2. Timed Up & Go functional test

    Time frame: before the intervention and two weeks later, one month and three months after the intervention

    n this evaluation, the patient will be asked to get up from a standard chair and walk along a line drawn on the floor in front of a three-meter long chair in a completely comfortable and safe manner, then go around and walk again. Return to the side of the chair and sit on it. The time to perform this test will be measured with a stopwatch and recorded in seconds.

  3. Six-Minute Walk Functional Test

    Time frame: before the intervention and two weeks later, one month and three months after the intervention

    In this evaluation, the patient will be asked to walk the maximum distance he can within 6 minutes. The distance traveled by the patient during the test will be measured with a tape measure and recorded with a meter unit.

    Each of these functional evaluations is repeated three times and the best result for the patient will be recorded

Sponsors and collaborators

Lead sponsor

Ahmad Nazari

Other

Registry information

Official study title

Evaluation of the Effect of Different Doses of Ozone Therapy on Pain and Function of Patients With Knee Osteoarthritis Referred to the Sports Medicine Clinic of Hazrat Rasool Akram Hospital

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 18, 2023
Registry last updated
Jul 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.